BioNexus Gene Lab Corp. (BGLC) Deferred Tax Assets, Capital Loss Carryforwards

BioNexus Gene Lab Corp. Deferred Tax Assets, Capital Loss Carryforwards

BioNexus Gene Lab Corp. (BGLC) had Deferred Tax Assets, Capital Loss Carryforwards of $376.02 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.

Financial Statements › Notes › Income Taxes › Components of Deferred Tax Assets and Liabilities › Components of Deferred Tax Assets › Deferred Tax Assets, Net of Valuation Allowance › Deferred Tax Assets, Gross

us-gaap:DeferredTaxAssetsCapitalLossCarryforwards · last filed 2026-08-14

• 2026-06-30: Deferred Tax Assets, Capital Loss Carryforwards $376.02K.
• 2026-03-31: Deferred Tax Assets, Capital Loss Carryforwards $358.69K.
• 2025-12-31: Deferred Tax Assets, Capital Loss Carryforwards $340.39K; Deferred Tax Assets, Capital Loss Carryforwards as first filed $315.69K.
• 2024-12-31: Deferred Tax Assets, Capital Loss Carryforwards $204.40K.